Stryker PE Ratio 2006-2018 | SYK

Current and historical price to earnings ratio for Stryker (SYK) from 2006 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. The current PE ratio for Stryker as of August 17, 2018 is 24.56.
Stryker Annual PE Ratio
Stryker Quarterly PE Ratio
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $63.571B $12.444B
Stryker Corporation is one of the world's leading medical technology companies and together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $122.465B 18.95
Abbott Laboratories (ABT) United States $113.540B 23.79
Boston Scientific (BSX) United States $47.586B 24.75
Baxter (BAX) United States $38.489B 26.20
Zimmer Biomet Holdings (ZBH) United States $25.204B 16.19
Smith & Nephew SNATS (SNN) United Kingdom $15.640B 0.00
ResMed (RMD) United States $15.244B 30.25
Perrigo (PRGO) Ireland $9.983B 14.17
Bio-Rad Laboratories (BIO) United States $9.444B 60.64
Canopy Growth (CGC) Canada $7.445B 0.00
Hill-Rom Holdings (HRC) United States $6.341B 21.51
ICU Medical (ICUI) United States $6.026B 40.83
Haemonetics (HAE) United States $5.351B 48.83
Insulet (PODD) United States $5.209B 0.00
Agios Pharmaceuticals (AGIO) United States $4.408B 0.00
Neogen (NEOG) United States $4.360B 69.38
Hutchison China MediTech (HCM) China $3.903B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.778B 0.00
NuVasive (NUVA) United States $3.598B 34.13
National Vision Holdings (EYE) United States $3.054B 67.43
Quidel (QDEL) United States $2.769B 56.74
Phibro Animal Health (PAHC) United States $1.990B 29.55
NxStage Medical (NXTM) United States $1.846B 0.00
Cardiovascular Systems (CSII) United States $1.249B 751.20
Eagle Pharmaceuticals (EGRX) United States $1.176B 34.73
VAREX IMAGING (VREX) United States $1.130B 18.47
AtriCure (ATRC) United States $1.099B 0.00
Omeros (OMER) United States $1.016B 0.00
OraSure Technologies (OSUR) United States $1.001B 65.44
Owens & Minor (OMI) United States $0.990B 10.59
Surmodics (SRDX) United States $0.981B 118.47
TG Therapeutics (TGTX) United States $0.957B 0.00
Cerus (CERS) United States $0.922B 0.00
PetIQ (PETQ) United States $0.847B 29.00
MacroGenics (MGNX) United States $0.845B 0.00
LeMaitre Vascular (LMAT) United States $0.716B 34.34
Meridian Bioscience (VIVO) United States $0.632B 21.59
Insys Therapeutics (INSY) United States $0.574B 0.00
Evolus (EOLS) United States $0.527B 0.00
Lantheus Holdings (LNTH) United States $0.515B 16.01
NanoString Technologies (NSTG) United States $0.417B 0.00
Cytosorbents (CTSO) United States $0.363B 0.00
BioLife Solutions (BLFS) United States $0.325B 0.00
Utah Medical Products (UTMD) United States $0.324B 20.86
Quanterix (QTRX) United States $0.324B 0.00
Surface Oncology (SURF) United States $0.279B 0.00
Rockwell Medical (RMTI) United States $0.216B 0.00
Chimerix (CMRX) United States $0.195B 0.00
Fonar (FONR) United States $0.170B 10.34
Chembio Diagnostics (CEMI) United States $0.158B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.119B 0.00
Female Health (VERU) United States $0.115B 0.00
United-Guardian (UG) United States $0.086B 18.83
Trinity Biotech (TRIB) Ireland $0.085B 25.25
Oramed Pharmaceuticals (ORMP) Israel $0.082B 0.00
Neurotrope (NTRP) United States $0.075B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.064B 0.00
CAS Medical Systems (CASM) United States $0.061B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Valeritas Holdings (VLRX) United States $0.036B 0.00
Capricor Therapeutics (CAPR) United States $0.032B 0.00
Akers Biosciences Inc (AKER) United States $0.025B 0.00
Senestech (SNES) United States $0.021B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00